KR20210087959A - 직교 단백질 이종이량체 - Google Patents

직교 단백질 이종이량체 Download PDF

Info

Publication number
KR20210087959A
KR20210087959A KR1020217015999A KR20217015999A KR20210087959A KR 20210087959 A KR20210087959 A KR 20210087959A KR 1020217015999 A KR1020217015999 A KR 1020217015999A KR 20217015999 A KR20217015999 A KR 20217015999A KR 20210087959 A KR20210087959 A KR 20210087959A
Authority
KR
South Korea
Prior art keywords
polypeptide
target
domain
binding
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217015999A
Other languages
English (en)
Korean (ko)
Inventor
지보 첸
스콧 보이켄
쉐리 버메오
로버트 에이. 란간
데이비드 베이커
Original Assignee
유니버시티 오브 워싱톤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유니버시티 오브 워싱톤 filed Critical 유니버시티 오브 워싱톤
Publication of KR20210087959A publication Critical patent/KR20210087959A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/002—Biomolecular computers, i.e. using biomolecules, proteins, cells
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03K—PULSE TECHNIQUE
    • H03K19/00—Logic circuits, i.e. having at least two inputs acting on one output; Inverting circuits
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/10—Boolean models
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/30—Dynamic-time models
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/914—Protein engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Immunology (AREA)
  • Theoretical Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Mathematical Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Computing Systems (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Artificial Intelligence (AREA)
KR1020217015999A 2018-11-02 2019-11-04 직교 단백질 이종이량체 Ceased KR20210087959A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862755264P 2018-11-02 2018-11-02
US62/755,264 2018-11-02
US201962904800P 2019-09-24 2019-09-24
US62/904,800 2019-09-24
PCT/US2019/059654 WO2020093043A1 (en) 2018-11-02 2019-11-04 Orthogonal protein heterodimers

Publications (1)

Publication Number Publication Date
KR20210087959A true KR20210087959A (ko) 2021-07-13

Family

ID=68655751

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217015999A Ceased KR20210087959A (ko) 2018-11-02 2019-11-04 직교 단백질 이종이량체

Country Status (8)

Country Link
US (4) US11820800B2 (cg-RX-API-DMAC7.html)
EP (1) EP3873919A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022505866A (cg-RX-API-DMAC7.html)
KR (1) KR20210087959A (cg-RX-API-DMAC7.html)
CN (1) CN113272317A (cg-RX-API-DMAC7.html)
AU (1) AU2019371462A1 (cg-RX-API-DMAC7.html)
CA (1) CA3117841A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020093043A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210087959A (ko) * 2018-11-02 2021-07-13 유니버시티 오브 워싱톤 직교 단백질 이종이량체
US20230399660A1 (en) * 2020-10-23 2023-12-14 Altius Institute For Biomedical Sciences Cell Permeable Proteins for Genome Engineering
WO2022169913A2 (en) * 2021-02-02 2022-08-11 Outpace Bio, Inc. Synthetic degrader system for targeted protein degradation
WO2023288190A1 (en) * 2021-07-13 2023-01-19 University Of Washington Modular reconfigurable asymmetric protein assemblies
WO2023150649A2 (en) * 2022-02-02 2023-08-10 Outpace Bio, Inc. Synthetic degrader system for targeted protein degradation
US20250136652A1 (en) * 2022-03-02 2025-05-01 The Regents Of The University Of California Fusion protein for targeting recombinant proteins for degradation
WO2024026465A1 (en) * 2022-07-29 2024-02-01 The Broad Institute, Inc. Programmable pattern recognition compositions
WO2026055533A1 (en) * 2024-09-06 2026-03-12 The Regents Of The University Of California Synthetic receptors for engineered ligands

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012988A1 (en) * 1995-10-06 1997-04-10 Pence Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
NZ507886A (en) * 1998-05-19 2003-05-30 Avidex Ltd Multivalent T cell receptor complexes
WO2004007530A2 (en) * 2002-07-17 2004-01-22 The Center For Blood Research, Inc. Modified proteins stabilized in a desired conformation and methods for producing same
DK1999154T3 (da) 2006-03-24 2012-12-03 Merck Patent Gmbh Fremstillede heterodimere proteindomæner
US9217011B2 (en) * 2007-09-07 2015-12-22 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides
US20110224404A1 (en) 2010-03-11 2011-09-15 Florida State University Research Foundation Method for development of a peptide building block useful for de novo protein design
EP3436470A4 (en) 2016-04-01 2019-11-20 University of Washington POLYPEPTIDES FOR THE PREPARATION OF HOMOOLIGOMERS WITH MODULAR HYDROGEN BONDING NETWORKED SPECIFICITY AND THEIR DESIGN
US20180068054A1 (en) * 2016-09-06 2018-03-08 University Of Washington Hyperstable Constrained Peptides and Their Design
US10818377B2 (en) * 2016-11-16 2020-10-27 University Of Washington Computational design of self-assembling cyclic protein homo-oligomers
US20210363214A1 (en) * 2018-03-01 2021-11-25 University Of Washington Transmembrane polypeptides
CN112512544B (zh) * 2018-07-19 2025-09-09 华盛顿大学 蛋白质开关的全新设计
US20210324011A1 (en) * 2018-10-25 2021-10-21 University Of Washington Self-assembling protein homo-polymers
KR20210087959A (ko) * 2018-11-02 2021-07-13 유니버시티 오브 워싱톤 직교 단백질 이종이량체
KR20210111761A (ko) * 2018-12-04 2021-09-13 유니버시티 오브 워싱턴 단백질 기능 및 상호작용을 제어하기 위한 시약 및 방법
US12583896B2 (en) * 2019-01-07 2026-03-24 The Regents Of The University Of California Caged-degron-based molecular feedback circuits and methods of using the same
EP3908592A1 (en) * 2019-01-07 2021-11-17 University of Washington De novo design of protein switches for tunable control of protein degradation
WO2020214549A1 (en) * 2019-04-15 2020-10-22 University Of Washington Self-assembling 2d arrays with de novo protein building blocks
US20220144895A1 (en) * 2019-04-18 2022-05-12 University Of Washington De novo design of tunable ph-driven conformational switches
WO2020257225A1 (en) * 2019-06-17 2020-12-24 University Of Washington De novo design of phosphorylation inducible protein switches (phospho-switches)
WO2021158849A1 (en) * 2020-02-07 2021-08-12 University Of Washington Multipartite and circularly permuted beta-barrel polypeptides and methods for their use

Also Published As

Publication number Publication date
US20220017579A1 (en) 2022-01-20
AU2019371462A1 (en) 2021-05-20
JP2024149492A (ja) 2024-10-18
WO2020093043A1 (en) 2020-05-07
JP2022505866A (ja) 2022-01-14
CN113272317A (zh) 2021-08-17
US20220098250A1 (en) 2022-03-31
EP3873919A1 (en) 2021-09-08
US20210355175A1 (en) 2021-11-18
CA3117841A1 (en) 2020-05-07
US11820800B2 (en) 2023-11-21
US20240101615A1 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
US20240101615A1 (en) Orthogonal protein heterodimers
Hatano et al. Asgard archaea shed light on the evolutionary origins of the eukaryotic ubiquitin-ESCRT machinery
Tiede et al. Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications
Seeger et al. Design, construction, and characterization of a second‐generation DARPin library with reduced hydrophobicity
EP2956156B1 (en) Scaffold proteins derived from plant cystatins
Camarero et al. Peptide chemical ligation inside living cells: in vivo generation of a circular protein domain
Rupert et al. A new DNA-binding motif in the Skn-1 binding domain–DNA complex
Edgell et al. De novo designed protein-interaction modules for in-cell applications
JP2022517566A (ja) タンパク質分解の調整可能な制御のためのタンパク質スイッチの新規設計
Pham et al. Design of functional globular β‐Sheet miniproteins
CA2610976C (en) Use of stefin a as a scaffold protein
Mason et al. Role of hydrophobic and electrostatic interactions in coiled coil stability and specificity
Leng et al. De novo designed 3-helix bundle peptides and proteins with controlled topology and stability
Xie et al. Structural insights into the recognition of phosphorylated Hop1 by Mek1
Herrada et al. Purification and structural analysis of LEM-domain proteins
Minor Searching for interesting channels: pairing selection and molecular evolution methods to study ion channel structure and function
Petters et al. Design, expression and characterization of a highly stable tetratricopeptide-based protein scaffold for phage display application
WO2023288190A1 (en) Modular reconfigurable asymmetric protein assemblies
Nikolaev et al. Rethinking Leucine Zipper–a ubiquitous signal transduction motif
Hatano et al. Characterisation of the Ubiquitin-ESCRT pathway in Asgard archaea sheds new light on origins of membrane trafficking in eukaryotes
Panigrahi et al. The design and structure of outer membrane receptors from peroxisomes, mitochondria, and chloroplasts
Habibi Revealing the structural dynamics and functional properties of class II lanthipeptide synthetases using mass spectrometry-based techniques
Kim Recombinant Proteins for Biomedical Applications
Rajendran et al. Functional Nucleic Acid-Protein Complexes: Application to Fluorescent Ribonucleopeptide Sensors
Tököli Design Strategies for Protein-Protein Interaction Inhibitors Using Non-Natural Amino Acids

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601